Abstract:
The present invention provides a pharmaceutical composition comprising at least one selected from a group consisting of 8-hydroxy-7-iodo-5-quinoline sulfonic acid, 1-(2,4,6-trihydroxyphenyl)propan-1-one, and pharmaceutically acceptable salt thereof as an active ingredient for preventing or treating cancer. The composition can be valuably used for preventing or treating cancer.